Schroder Investment Management Group »

Enliven Therapeutics shares owned by Schroder Investment Management Group

Quarter-by-quarter ownership of Enliven Therapeutics shares owned by Schroder Investment Management Group from 13F filings

Historical chart of Schroder Investment Management Group investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Schroder Investment Management Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $646k 13k 50.85

More positions owned by Schroder Investment Management Group

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Morgan Stanley Com New (MS)
Arista Networks Com Shs (ANET)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Kla Corp Com New (KLAC)

View all positions for Schroder Investment Management Group

Top funds holding Enliven Therapeutics

Schroder Investment Management Group

View all funds holding Enliven Therapeutics